KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Other Non-Current Assets: 2010-2024

Historic Other Non-Current Assets for Nektar Therapeutics (NKTR) over the last 15 years, with Dec 2024 value amounting to $4.6 million.

  • Nektar Therapeutics' Other Non-Current Assets fell 84.40% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 84.40%. This contributed to the annual value of $4.6 million for FY2024, which is 0.06% up from last year.
  • According to the latest figures from FY2024, Nektar Therapeutics' Other Non-Current Assets is $4.6 million, which was up 0.06% from $4.6 million recorded in FY2023.
  • Nektar Therapeutics' 5-year Other Non-Current Assets high stood at $4.6 million for FY2024, and its period low was $1.5 million during FY2020.
  • In the last 3 years, Nektar Therapeutics' Other Non-Current Assets had a median value of $4.6 million in 2023 and averaged $3.8 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first soared by 324.71% in 2020, then fell by 18.19% in 2022.
  • Over the past 5 years, Nektar Therapeutics' Other Non-Current Assets (Yearly) stood at $1.5 million in 2020, then spiked by 87.82% to $2.7 million in 2021, then decreased by 18.19% to $2.2 million in 2022, then soared by 106.86% to $4.6 million in 2023, then rose by 0.06% to $4.6 million in 2024.